Siren LLC’s AgomAb Therapeutics NV AGMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.56M Hold
411,250
– – 0.11% 85
2026
Q2
$5.34M Hold
411,250
– – 0.11% 87
2026
Q1
$4.31M Buy
+411,250
New +$5.82M 0.12% 80

Other funds holding AGMB

Siren LLC's AGMB Position: Q3 2026 in Review

Siren LLC held its AgomAb Therapeutics NV (AGMB) position steady in Q3 2026 at 411,250 shares worth $4.56M. The position accounts for 0.11% of the portfolio, ranked #85.

Siren LLC first reported a position in AGMB in Q1 2026 and has held it in 3 quarters since. The position peaked at $5.34M in Q2 2026. 25 funds tracked by Wall St. Rank hold AGMB as of Q3 2026.

  • Siren LLC held 411,250 shares of AgomAb Therapeutics NV worth $4.56M as of Q3 2026.
  • Siren LLC left its AgomAb Therapeutics NV share count unchanged in Q3 2026.
  • AgomAb Therapeutics NV made up 0.11% of Siren LLC's portfolio in Q3 2026, its #85 holding.
  • Siren LLC first reported a position in AgomAb Therapeutics NV in Q1 2026 and has held it in 3 quarters since.
  • Siren LLC's AgomAb Therapeutics NV position peaked at $5.34M in Q2 2026.
  • 25 funds tracked by Wall St. Rank held AgomAb Therapeutics NV as of Q3 2026.

Based on Siren LLC's 13F filing for Q3 2026, filed 12 Nov 2026.